drugset / Trial / NCT00334399

Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

NCT00334399 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Miglitol Small molecule — —